ANTICORPS A DOMAINE UNIQUE POUR LE LIGAND DU RECEPTEUR DE MORT CELLULAIRE PROGRAMMEE (PD-L1) ET PROTEINE DERIVEE DE CELUI-CI

• 收藏
• 分享

专利权人:

SUZHOU ALPHAMAB CO., LTD.; LTD.;3D MEDICINES (BEIJING) CO., LTD.;SUZHOU ALPHAMAB CO.

发明人:

XU, TING,DONG, YANRONG,WANG, PILIN,CHEN, TING

申请号：

CA2994339

公开号：

CA2994339A1

申请日:

2016.08.01

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

The present invention relates to the biomedical field, and provides a single domain antibody for programmed death-ligand (PD-L1) and a derived protein thereof. The present invention also provides a use of a PD-L1 binding molecule in treating and/or preventing and diagnosing a PD-L1 related disease, such as tumor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/